Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Boursi

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
European Journal of Internal Medicine|January 15, 2013
One stop screening for multiple cancers: the experience of an integrated cancer prevention centerTal Sella, Ben Boursi, Amira Gat-Charlap, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Nuclear Export Inhibition for Radiosensitization: A Proof-of-Concept Phase 1 Clinical Trial of Selinexor (KPT-330) Combined With Neoadjuvant Chemoradiation in Locally Advanced Rectal CancerYaacov R Lawrence, Einat Shacham-Shmueli, Nirit Yarom, et al.
Clinical Colorectal Cancer|September 1, 2023
Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver MetastasesOfer Margalit, Sivan Lieberman, Ilanit Redinsky, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2023
Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170Ofer Margalit, William S Harmsen, Einat Shacham-Shmueli, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2022
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD databaseOfer Margalit, William S Harmsen, Einat Shacham-Shmueli, et al.
Science (New York, N.Y.)|December 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsErez N Baruch, Ilan Youngster, Guy Ben-Betzalel, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
European Journal of Internal Medicine|January 15, 2013
One stop screening for multiple cancers: the experience of an integrated cancer prevention centerTal Sella, Ben Boursi, Amira Gat-Charlap, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Nuclear Export Inhibition for Radiosensitization: A Proof-of-Concept Phase 1 Clinical Trial of Selinexor (KPT-330) Combined With Neoadjuvant Chemoradiation in Locally Advanced Rectal CancerYaacov R Lawrence, Einat Shacham-Shmueli, Nirit Yarom, et al.
Clinical Colorectal Cancer|September 1, 2023
Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver MetastasesOfer Margalit, Sivan Lieberman, Ilanit Redinsky, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2023
Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170Ofer Margalit, William S Harmsen, Einat Shacham-Shmueli, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2022
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD databaseOfer Margalit, William S Harmsen, Einat Shacham-Shmueli, et al.
Science (New York, N.Y.)|December 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsErez N Baruch, Ilan Youngster, Guy Ben-Betzalel, et al.
Pageof 11